SkinBioTherapeutics Plc

Image result for SkinBioTherapeutics

SkinBioTherapeutics is a life science company focused on skin health. The SkinBioTherapeutics’ platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin.

SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control and eczema. In each of these areas SkinBioTherapeutics plans to exemplify its technology in human studies. The most advanced programme is focused on the application of the Skinbiotix® platform in managing sensitive skin in the cosmetics industry. The business strategy is to partner and outlicense its programmes at proof of concept.

Read more about SkinBio here

 


Warning

This website makes reference to the previous rounds of investments made by Seneca Partners on behalf of certain investors within the Seneca EIS Portfolio Service. The rationale for the investment may no longer be valid. Under no circumstances should you take this information as a recommendation by Seneca Partners for you to invest in the Service or in any of the companies listed above.

Get in touch

For administrative and shareholder queries, please contact the Seneca EIS Team

For sales or other general queries, please contact the Seneca EIS Team or LGBR Capital